Publications by authors named "Sophia M DiCesare"

Article Synopsis
  • Malattia Leventinese/Doyne honeycomb retinal dystrophy (ML/DHRD) is a form of retinal degeneration linked to a specific genetic mutation in the fibulin-3 protein, similar to age-related macular degeneration (AMD).
  • Researchers developed a method to track fibulin-3 levels in retinal cells and found that the GSK3 inhibitor CHIR99021 effectively reduced its production and altered cell behavior.
  • In tests on mice with the ML/DHRD mutation, CHIR treatment significantly decreased harmful structures associated with the disease, suggesting its potential for treating AMD and similar retinal disorders.
View Article and Find Full Text PDF

Activated microglia have been implicated in the pathogenesis of age-related macular degeneration (AMD), diabetic retinopathy, and other neurodegenerative and neuroinflammatory disorders, but our understanding of the mechanisms behind their activation is in infant stages. With the goal of identifying novel genes associated with microglial activation in the retina, we applied a semiquantitative fundus spot scoring scale to an unbiased, state-of-the-science mouse forward genetics pipeline. A mutation in the gene encoding the E3 ubiquitin ligase Herc3 led to prominent accumulation of fundus spots.

View Article and Find Full Text PDF

Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy (ML/DHRD) is an age-related macular degeneration (AMD)-like retinal dystrophy caused by an autosomal dominant R345W mutation in the secreted glycoprotein, fibulin-3 (F3). To identify new small molecules that reduce F3 production from retinal pigmented epithelium (RPE) cells, we knocked-in a luminescent peptide tag (HiBiT) into the endogenous F3 locus which enabled simple, sensitive, and high throughput detection of the protein. The GSK3 inhibitor, CHIR99021 (CHIR), significantly reduced F3 burden (expression, secretion, and intracellular levels) in immortalized RPE and non-RPE cells.

View Article and Find Full Text PDF

Fibulin-3 (F3 or EFEMP1) is a disulfide-rich, secreted glycoprotein necessary for maintaining extracellular matrix (ECM) and connective tissue integrity. Three studies have identified distinct autosomal recessive F3 mutations in individuals with Marfan Syndrome-like phenotypes. Herein, we characterize how one of these mutations, c.

View Article and Find Full Text PDF